1Division of Digestive Diseases and Nutrition, University of South Carolina School of Medicine, Columbia.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Omeprazole effectively inhibits gastric acid secretion by targeting the H+/K+-ATPase proton pump. This medication is approved for severe gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome, with recommendations for duodenal ulcer treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: